Hypoxic preconditioning (8% O 2 , 3 hr) produces tolerance 24 hr after hypoxic-ischemic brain injury in neonatal rats. To better understand the ischemic tolerance mechanisms induced by hypoxia, we used oligonucleotide microarrays to examine genomic responses in neonatal rat brain following 3 hr of hypoxia (8% O 2 ) and either 0, 6, 18 or 24 hr of re-oxygenation. The results showed that HIF-1-but not HIF-2-mediated gene expression may be involved in brain hypoxia-induced tolerance. Among the genes regulated by hypoxia, 12 genes were confirmed by real-time RT-PCR: VEGF, EPO, GLUT-1, adrenomedullin, proly 4-hydroxylase α, MT-1, MKP-1, CELF, 12-lipoxygenase, t-PA, CAR-1 and an expressed sequence tag (EST). Some genes, for example GLUT-1, MT-1, CELF, MKP-1 and t-PA didn't show any hypoxic regulation in either astrocytes or neurons, suggesting that other cells are responsible for the upregulation of these genes in the hypoxic brain. These genes were expressed in normal and hypoxic brain, heart, kidney, liver and lung, with adrenomedullin, MT-1 and VEGF being prominently induced in brain by hypoxia. These results suggest that a number of endogenous molecular mechanisms may explain how hypoxic preconditioning protects against subsequent ischemia, and may provide novel therapeutic targets for treatment of cerebral ischemia.
INTRODUCTION
Impaired oxygen (hypoxia) or reduced blood flow (ischemia) to the brain is a major cause of morbidity and mortality in the perinatal period, often resulting in cognitive impairment, seizures and other neurological disabilities. Though hypoxia-ischemia animal models have increased our understanding of the processes leading to cell death, there are still no pharmacological treatments available to reduce cell death in ischemic neonatal brain.
Interestingly, cells can be protected when a non-injurious hypoxic stress is performed several hours or days before a lethal hypoxic-ischemic stress (preconditioning). This phenomenon is called tolerance. Ischemic tolerance can be achieved in brain by several preconditioning sublethal stresses such as hypoxia (1) (2) (3) , ischemia itself (4), hypothermia (5), hyperthermia (6) , hyperbaric oxygenation (7), metabolic inhibitors (8) , spreading depression (9) as well as cytokines (10,11).
As hypoxic preconditioning is non-invasive and reproducible, this model has been used to study the mechanisms protecting the brain against hypoxia-ischemia particularly in newborn rats (3, (12) (13) (14) . In addition, hypoxic preconditioning also induces tolerance against focal transient (15) and permanent (16) cerebral ischemia in adult mice. These studies suggested that hypoxia inducible factor-1 (HIF-1) could be an important mediator of hypoxia-induced tolerance to ischemia (13, 14, 16) . Indeed, hypoxic preconditioning induces expression of HIF-7 Reagent (Life Technology, Rockville, Maryland) according to the manufacturer's protocol.
Briefly, the tissue pellets were homogenized in Trizol Reagent using a syringe. After extraction with chloroform (an additional step of phenol/chloroform extraction is added to the manufacturer's protocol), RNA was precipitated by isopropyl alcohol and subjected to further purification using an RNeasy mini kit (Qiagen, Valencia, California). The quality and quantity of extracted total RNA samples were examined by loading 5 µg of each sample on a denaturating agarose gel.
Microarray analysis. Microarray expression analysis was performed according to the Affymetrix expression analysis technical manual (Affymetrix GeneChip® Expression Analysis
Manual, P/N 700217 to 700222, Affymetrix, Santa Clara, California). Double stranded cDNA is synthesized from total RNA. To synthesize the first cDNA strand, a HPLC-purified oligo-dT primer was annealed to the RNA and extension by reverse transcriptase was performed in the presence of deoxy-oligonucleotides. The second strand was synthesized using DNA polymerase I. Double stranded cDNA was purified using a modified phenol/chloroform extraction procedure (Eppendorf-5 Prime, Boulder, Colorado), followed by ethanol precipitation. An in vitro transcription was performed to produce biotin-labeled cRNA from the cDNA. cRNA was synthesized using T7 RNA polymerase and biotin labeled ribonucleotides and purified with affinity columns (Qiagen) followed by ethanol precipitation. No amplification procedure was performed to produce the final cRNA. The amount of product was quantified by spectrophotometric analysis, and the quality of the cRNA was assessed by gel electrophoresis and a test array (Test-2 chip). Once prepared, cRNA was hybridized to Affymetrix U34A rat arrays (Affymetrix), which contains more than 7000 genes and 1000 ESTs (expressed sequence tags referred to as genes in the following text). The hybridization cocktail, containing the cRNA sample, BSA, and herring sperm DNA, was incubated at 99°C, transferred to 45°C, and then injected into the microarray chamber (Affymetrix). Hybridization was performed automatically in a chamber at 45°C for 16 hr while being rotated at 60 rpm. The hybridized probe array was then automatically washed, dried, and scanned two times at an excitation wavelength of 488nm.
Microarray Data Analysis.
For microarray analysis, we used total RNA prepared from 2 animals for each group (6 groups in total): 4 "hypoxia 3 hr groups" with 0, 6, 18 or 24 hr of reoxygenation and 2 "controls groups" (6 d-old rat pups that correspond to the sham-control of the hypoxia 3 hr with 0 hr of re-oxygenation and 7-d-old rat pups that correspond to the shamcontrol of the hypoxia 3 hr with 24 hr of re-oxygenation) (Fig. 1) . Two animals were used for each experimental group thus 12 arrays were used in total. The Affymetrix rat U34A array contains more than 7000 genes and 1000 ESTs.
The Affymetrix Genechip software MAS 4.0 (Affymetrix) was used first to collect and process the original expression data from the 12 rat Affymetrix arrays. Each gene on the array is assessed using 16 probe pairs. Each probe pair consists of an oligomer (25 base long) that is designed to be perfectly complementary to a particular message (called the perfect match or PM) and a companion oligomer that is identical to the PM probe except for a single base difference in a central position (called the mismatch or MM probe). The mismatch probe serves as a control for hybridization specificity and helps subtract non-specific hybridization. After hybridization intensity data is captured, the Affymetrix Genechip software automatically calculates intensity values for each probe cell and uses these probe cell intensities to calculate an average intensity for each gene (called average difference), which directly correlates with mRNA abundance. The software also gives each gene a qualitative assessment of "present" or "absent" based on a "voting scheme", with the number of instances in which the PM signal is significantly larger than the MM signal across the whole probe set. Prior to comparing any two measurements, a scaling procedure is performed so that all signal intensities on an array are multiplied by a factor that makes the mean PM-MM value for each array equal to a preset value 1500. The scaling corrects for any inter-array differences or small differences in sample concentration, labeling efficiency or fluorescence detection and makes inter-array more reproducible. In the case of a pair wise comparison of two array results, the patterns of change of the whole probe set (with consistent voting) is used to make a qualitative call (called difference call) of "Increase", "Decrease", "Marginally increase", "Marginally decrease" or "No change". The fold change is derived by the ratio of average differences from one experimental compared to a control array.
In order to eliminate possible expression changes related to the development (difference of RNA expression between 6-and 7 d-old rat pups) all groups were compared to both controls at 6 and 7 d old. To obtain differentially expressed genes for each condition, Affymetrix
Genechip software was used to compare 2 experimental arrays to the 4 control arrays (P6 and P7). For example, 6 hr (1) of re-oxygenation was compared to controls P6 (1) (2) and controls P7 (1) (2), respectively, then 6 hr (2) was compared to controls P6 (1) (2) and controls P7 (1) (2) . As a result, there were 8 comparisons for each condition. Absolute calls (present, marginal, absent) and the average difference (RNA abundance) for each gene on each chip were then imported into Genespring software (Silicon Genetics, Redwood City, California) for further analysis.
By combining the fold change and the present calls derived from the 8 comparisons, we obtained a list for each condition. The criteria for the lists were: (1) The fold change for each of the 8 comparisons was at least 1.5 fold. (2) There were present calls in all the hypoxic groups for increasing gene expression and present calls in both controls for decreasing gene expression.
(3) Raw data are greater than 100 in hypoxic samples for up-regulated genes and in control samples for down-regulated genes. To avoid developmental gene expression changes, genes that were increased or decreased more than 1.5 fold between 6 d-old and 7 d-old controls were eliminated from the list of hypoxic changes.
To obtain a general view of brain genomic response to hypoxia, genes regulated at different time points following hypoxia were selected by the Significance Analysis of Microarrays (SAM) software (27) . Among those genes, 285 genes with relatively high expression in most samples (raw data at least 100 in 7 out of 12 samples) were subjected to hierarchical cluster analysis with Genespring software. A standard correlation coefficient of 0.95 was used as the measure for significant statistical similarity. The branching behavior of the tree was controlled using a separation ration setting of 0.5 and a minimum distance setting of 0.001.
Real-time Q-RT-PCR.
To validate the microarray data, TaqMan quantitative one-step reverse transcriptase-polymerase chain reaction (Q-RT-PCR) was used to quantitate mRNA levels for selected genes. Two primers and one probe (TaqMan probe) (Applied Biosystems, Foster City, CA) were designed for each genes using Perkin-Elmer PrimerExpress software (Applied Biosystems). Q-RT-PCR was performed for whole brain hemisphere RNA from at least 3 animals for each of the groups (including the same RNA samples from 2 animals employed for microarrays analysis) and from heart, kidney, liver and lung RNA from 3 animals submitted or not to 3 hr of hypoxia with or without re-oxygenation. Primer and probe sequences are listed for forward primers "F", reverse primers "R" and TaqMan probes "T" in Table 1 .
TaqMan probes were labeled with VIC on the 5' nucleotide and TAMRA on the 3' nucleotide. Preparation of total and nuclear protein extracts. Total and nuclear protein extracts were prepared from whole brain hemisphere tissue lysates after 3 hr of hypoxia or 3 hr of hypoxia followed by 24 hr of re-oxygenation and controls ( 
RESULTS

Effect of hypoxic preconditioning on brain HIF-1 and HIF-2 expression
HIF-1 is a heterodimer made of two protein subunits, HIF-1α and HIF-1β (28) . Whereas HIF-1β is constitutively expressed, HIF-1α expression is tightly regulated by cellular oxygen concentration (29) . Thus HIF-1α determines HIF-1 DNA-binding activity and transcriptional activity during hypoxia. As 3 hr of hypoxia 8% O 2 is known to induce expression of HIF-1α and its target genes in neonatal brain (13, 14) , we examined the expression of this transcriptional factor in the current study. As shown in Figure 2 , exposure of neonatal P6 rats to hypoxia (8% O 2 , 3 hr) induced an increase in HIF-1α expression in total and nuclear extracts of the whole hemisphere ( Fig. 2 , 0 hr, +), when compared to control animals ( Fig. 2, 0 hr, -). Twenty-four hours following exposure to hypoxia, HIF-1α expression is reduced to control levels (Fig. 2, 24 hr, +). Whereas no significant changes in HIF-1β expression were observed in total extracts, a slight increase was observed in nuclear extracts after 3 hr of hypoxia (Fig. 2, 0 hr, +), suggesting that hypoxia didn't change the total content of HIF-1β but increased the translocation of HIF-1β into the nucleus (Fig. 2) .
Recently, a novel hypoxia-inducible factor HIF-2α (also known as EPAS1, MOP2, HRF, HLF) was identified and also binds as a heterodimer with HIF-1β to the hypoxia-response element. HIF-2α shares 48% identity with the HIF-1α protein (30) . The protein levels of HIF-2α also increase following hypoxia in various cell lines (30) . However, the influence of hypoxia on HIF-2α expression in the brain is still completly unknown. As shown in Figure 2 , one band (molecular weight around 120 kD) appeared for HIF-2α in both normoxic and hypoxic brain total protein extracts. The results show that HIF-2α is constitutively expressed in the brain and that HIF-2α expression is higher than that of HIF-1α, but no significant increase in HIF-2α expression was observed after hypoxia. These findings indicate that HIF-1α is more inducible by hypoxia than HIF-2α in the neonatal rat brain and suggest that HIF-1α could play a role in mediating the preconditioning effects of hypoxia.
Brain genomic response and its time course following hypoxic preconditioning
High-density oligonucleotide microarrays (Affymetrix, U34A for rat) were used to study the temporal profile of the brain genomic response in neonatal rat (6-7 d old) after 3 hr of hypoxia (8% O 2 ) followed by 0, 6, 18 or 24 hr of re-oxygenation. For this purpose, we used 2 animals / time point.
In order to avoid gene expression changes related to development (difference of RNA expression between 6-and 7 d-old rat pups) all groups were compared to both 6 and 7 d-old controls, and genes that were increased or decreased more than 1.5 fold between 6 d-old and 7 d-old controls were eliminated from the list of genes showing hypoxic changes. The developmentally regulated genes are presented in Table 2 . Among these genes, 14 are upregulated and 31 are down-regulated. Its interesting that genes known to be implicated in angiogenesis or neurogenesis (for example, VEGF-B, HES-5, FGFR-2) (31-33), decreased with age in accordance with the fact that these processes may become less important with older ages.
For the analysis of up-regulated genes or down-regulated genes, there were 8 comparisons for each condition. Absolute calls (present, marginal, absent) and the average difference (RNA abundance) for each gene on each chip obtained from Affymetrix software were then imported into Genespring software for further analysis. A general view of genes regulated by hypoxia/re-oxygenation is presented in Figures 3 and 4 . Figure 3 shows genes grouped according to their temporal expression pattern using a hierarchical clustering algorithm. Figure 4 summarizes the number of genes up-regulated or down-regulated using the stringent criteria described in the materials and methods. Some of these genes have only been identified as partially expressed sequence tags (EST) that encode for unknown proteins.
Up-regulated genes.
Hypoxia 3 hr increased the expression of 18 genes, which then progressively decreased as a function of re-oxygenation times (15 after 6 hr, 4 after 18 hr or 5 after 24 hr of reoxygenation) (Fig. 4) . This strong up-regulation of genes during hypoxia rather than reoxygenation is also shown with the cluster analysis in Figure 3 . Interestingly, only 1 gene which is an EST (GenBank Accession Number AA799328) was up-regulated at all the time points transporters, channels, proteases, genes implicated in apoptosis, detoxification, inflammation, vasodilatation, collagen synthesis and membrane trafficking. Among these genes, it is worthwhile to point out that the EST (GenBank Accession Number AA799328), which is increased at all the time points, also corresponds to the gene maximally increased by hypoxia/re-oxygenation (around 10 fold increase for all the time points) ( Table 3) . To validate these microarray data, real time Q-RT-PCR was performed on brain RNA prepared from 3 animals/time point for several candidates. We confirmed 10 up-regulated genes by Q-RT-PCR and for nearly all of the genes, the fold changes obtained with Q-RT-PCR were very similar to those obtained by microarray analysis (Fig. 5) . We focused our analysis on 4 HIF-1 target genes already known (VEGF, GLUT-1, adrenomedullin, prolyl 4-hydroxylase α), the hypoxiaresponsive genes MT-1 and MKP-1 and other novel hypoxia-responsive genes : CELF (C/EBP delta), 12-lipoxygenase, t-PA (tissue-type plasminogen activator) and EST AA799328. As shown in Figure 5A , the time course of expression after hypoxia/re-oxygenation of the four HIF-1 target genes was very similar: increase of expression occured during hypoxia but then returned to control level with re-oxygenation. A similar pattern of expression was also observed for MKP-1, a phosphatase known to be induced by hypoxia (22,23) but not known to be under HIF-1 control, and for 3 novel hypoxia-responsive genes (CELF, 12-lipoxygenase, t-PA) (Fig.   5B ). However, a different time course of induction was observed for MT-1 and EST AA799328 for which the increase of expression by hypoxia is maintained until 6 hr or 24 hr of reoxygenation, respectively (Fig. 5C ). We were surprised not to find an increase of erythropoietin (EPO) expression by hypoxia in the microarray data, since it has been widely described as a HIF-1 target gene and is induced by hypoxia in many organs including the brain (26, (39) (40) (41) .
Indeed, the real time Q-RT-PCR results showed an increase of EPO mRNA expression after 3 hr of hypoxia (Fig. 5D) . The raw data of EPO expression in the microarray results were, at all the time points tested, equal to zero, suggesting that the probes designed for this gene were not hybridizating to the EPO cRNA.
Down-regulated genes.
Hypoxia of 3 hr decreased the expression of 5 genes (Table 5) . However, the maximal number of genes down-regulated by hypoxia occured at 6 to 24 hr following re-oxygenation (Table 5 , Fig. 3, 4) . Interestingly, only 1 gene which is an EST (GenBank Accession Number AA799671) is down-regulated at all the time points analyzed ( Table 5 ). The list of downregulated genes included genes implicated in signal transduction, cell adhesion, DNA synthesis, cell cycle, structure, membrane trafficking and metabolism. Among the down-regulated genes, we confirmed by real-time Q-RT-PCR that 3hr of hypoxia decrease the expression of cell adhesion regulator-1 (CAR-1) mRNA, a gene encoding for a cell adhesion regulator protein (Fig. 5E ).
Expression of hypoxia regulated genes in neurons and astrocytes
In order to elucidate the possible cellular source of the genes regulated by hypoxia, we studied the expression of these same genes in cultured neurons and astrocytes using real-time Q-RT-PCR (VEGF, GLUT-1, proly 4-hydroxylase α, adrenomedullin, MKP-1, 12-lipoxygenase, t-PA, CELF, MT-1, EST AA799328, EPO and CAR-1). RNA was obtained from rat primary astrocytes or neurons cultures exposed to hypoxia or ambient oxygen for 3 hr. 
Comparison of the genomic response following hypoxic preconditioning in various organs
To determine whether the hypoxia-induced gene expression changes observed in neonatal rat brain occur in other organs, we compared the brain expression of the genes confirmed by Q-RT-PCR to other organs (heart, kidney, liver, lung) after 3 hr of hypoxia. The results, presented in Figure 6 , revealed 5 major groups: A/ genes up-regulated at a similar level in all organs (12-lipoxygenase, t-PA, MKP-1, CELF); B/ genes more regulated in brain (adrenomedullin, MT-1, VEGF, CAR-1); C/ genes up-regulated at a similar level in brain and heart (EST GenBank Accession Number AA799328); D/ genes up-regulated at a similar level in all organs except lung (proly 4-hydroxylase α); E/ genes much more up-regulated in liver or kidney (GLUT-1, EPO).
DISCUSSION
The results confirm that hypoxia induces HIF-1α and its target genes in newborn rat brain (13) . Though HIF-2α, a HIF-1α homologue, is induced by cerebral ischemia (42) and by hypoxia in some cells (30) , it was unknown whether hypoxia-preconditioning would induce HIF-2α in brain. The data shows that HIF-2α is expressed in normoxia, but is not induced by 3-hr hypoxia in neonatal rat brain. This is consistent with previous studies showing higher expression of HIF-2α than HIF-1α under normoxia and variable hypoxic induction of HIF-2α in different cell types (30) . Whereas HIF-1α is expressed and regulated by hypoxia in most cells, HIF-2α is expressed mainly in endothelial cells (30) . HIF-2α appears to modulate gene expression in endothelial cells during normoxia and less severe hypoxia (30) . Therefore, HIF-1α-but not HIF-2α−mediated gene expression may be involved in brain hypoxia-induced tolerance (13, 14, 43) . This suggests that these genes may be new HIF-1 target genes. Indeed, cobalt chloride and desferrioxamine, two agents activating HIF-1 (17) , mimic the hypoxic increase of MKP-1 gene in PC12 cells (23).
The possible contribution of these hypoxia-inducible genes in hypoxia-induced tolerance is supported by several previous studies. VEGF (18) and EPO (11, 19, 20) protect the brain against ischemia/hypoxia. Astrocytes are an important source of endogenous VEGF and EPO during hypoxia (26, (39) (40) (41) . GLUT-1, another HIF-1 target, may also be involved in hypoxiainduced ischemic tolerance (14) . Though GLUT-1 mRNA is up-regulated by hypoxia in neurons and astrocytes (44), our results suggest that other cells, like endothelial cells, may be involved. Indeed, GLUT-1 is highly expressed in endothelial cells at the blood-brain barrier (45) and hypoxia increases this expression (46) . Prolyl 4-hydroxylase α, an active subunit that catalyzes oxygen-dependent hydroxylation of proline residues in procollagen, is also a HIF-1 target gene (38) . The loss of basal lamina, including type IV collagen, compromises microvascular integrity in cerebral ischemia that likely contributes to edema and hemorrhage (47) . Hypoxia-preconditioning may protect in part by increasing prolyl 4-hydroxylase α expression, and therefore decreasing loss of vascular integrity induced by ischemia.
Adrenomedullin, a vasodilatory peptide, is also transcriptionally regulated by HIF-1 (37) and reduces ischemic brain injury in rats (48) . Adrenomedullin appears to be induced by hypoxia in neurons. MKP-1, a MAP kinase phosphatase and another putative HIF-1 target (23), improves survival of PC12 and other cells by antagonizing c-jun-N-terminal kinase (JNK) activation (49, 50) . JNK levels increase after ischemia. This can be abrogated by ischemia-preconditioning, which also protected against ischemic injury (51). Thus, hypoxic or ischemic preconditioning may reduce ischemic JNK activation and protect the brain through a common MKP-1 pathway.
Hypoxic induction of MKP-1 expression does not appear to be localized to neurons or astrocytes. This is the first demonstration that hypoxia induces 12-lipoxygenase in brain and that this occurs in astrocytes. There is no report on the role of 12-lipoxygenase in cerebral ischemia. However, ischemic preconditioning-induced cardio-protection is impaired in 12-lipoxygenase-deficient mice and by 12-lipoxygenase inhibitors (52, 53) . This data supports the possibility that 12-lipoxygenase could also be involved in hypoxia-induced ischemic tolerance.
The transcription factor CELF (also named C/EBP delta, CRP3 and NF-IL6β) is also induced by hypoxia, likely in cells other than neurons or astrocytes. CELF participates in the transcriptional regulation of many molecules that have been shown to be protective and/or detrimental in ischemia such as cyclooxygenase-2 (COX-2) (54), nerve growth factor (55), complement component C3 (56) and peroxisome proliferator-activated receptor gamma 2 (57).
COX-2 inhibitors decrease injury (58), whereas COX-2 mediates the protective effects of cardiac ischemic preconditioning (59) . Thus, depending on the cell type expressing CELF and CELF target genes, CELF could either help or harm. A similar hypothesis could be proposed for t-PA since hypoxia increased its expression in whole brain, and tPA can protect or be detrimental in cerebral ischemia (60) . Hypoxia-preconditioning has been shown to induce both MT-1 and MT-2 (61), and both molecules protect against cerebral ischemia (62,63).
Hypoxia not only increased but also decreased gene expression. For example, the cell adhesion regulator CAR-1 decreased following hypoxia. In addition, hypoxia decreased its expression in neurons but increased it in astrocytes. The difference observed in CAR-1 expression from different cell types suggests that the cellular mechanisms by which CAR-1 expression is regulated by hypoxia are different among various cell types in brain. This may be true for other genes as well.
The current results along with those in literature strongly support an important role of VEGF, EPO, GLUT-1, proly 4-hydroxylase α, adrenomedullin, MKP-1, 12-lipoxygenase, t-PA, CELF, MT-1 and CAR-1 in brain ischemic tolerance induced by hypoxia in neonatal rats.
Moreover, the data showed that hypoxia increased expression of glutamate transporter EAAT4 (excitatory amino acid transporter 4) in addition to that of EAAC1 (excitatory amino acid carrier 1), GLT-1 (glutamate transporter-1), EAAT2 and EAAT3 as previously published (64, 65) . Thus, hypoxic preconditioning may counteract the decrease of glutamate transporters induced by hypoxia-ischemia (66) and protect cells from high extracellular concentrations of glutamate by increasing its uptake. Furthermore, the present study shows that, in addition to ATP-dependent potassium channel known to participate in ischemic tolerance (67) , calciumand voltage-potassium channels may be important. In addition, many of the genes not discussed here, and many more genes not surveyed by the current microarrays are also likely to be involved in conferring hypoxia-induced ischemic tolerance.
Most of the genes that appear to be regulated by hypoxia in brain may be of importance in many other organs, and may represent common mechanisms of hypoxia-induced tolerance in all organs. However, some genes may play a specific role in the hypoxic brain. For example, adrenomedullin was induced by hypoxia in brain but not in heart, kidney, liver and lung in neonatal rats, pointing to a unique but unknown hypoxia-induced role for brain adrenomedullin in the neonate.
Limitations of the present study should be mentioned. First, it is the protein expression in cells that would mediate hypoxia-induced tolerance, and increased transcription does not always imply increased translation. Technical issues are limiting, since the entire rat genome was not surveyed here. In addition, as the EPO data show, some of the microarray data may be incomplete or wrong. The experimental paradigm used has limitations. For example, Egr-1 (early-growth-response gene) is induced by hypoxia, and therefore represents another important oxygen-regulated transcription factor independent of HIF-1 (68). However, our results only showed a marginal regulation of this gene by hypoxia. Because induction of egr-1 mRNA reaches a maximum at 30 min of hypoxia and then decreases (69) , and that the shortest time of hypoxia used in the present study was 3 hr, Egr-1 could mediate the brain genomic response to hypoxia. This could also be true for a number of other genes like c-fos and other immediate early genes. This could mean that many of the hypoxia-inducible genes observed here are immediate early gene targets requiring the co-activation by HIF-1, Egr-1, and/or other immediate early transcription factors. 
